Skip to content

Clinical trials

Phase 1 Cytokine Release Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cytokine Release Syndrome Phase: Phase 1 Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20161
20191
20211
20221
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting3
Active, not recruiting2
Completed2
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UNC Lineberger Comprehensive Cancer Center2
Cancer Research UK1
Institute of Hematology & Blood Diseases Hospital, China1
Liping Dou1
Noveome Biotherapeutics, formerly Stemnion1
Taylor Brooks1
University Hospital, Basel, Switzerland1
University of Pennsylvania1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cytokine Release Syndrome9
Recurrence3
Immune System Diseases2
Immunoproliferative Disorders2
Lymphoma, B-Cell2
Lymphoma, Non-Hodgkin2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
COVID-191
Leukemia1
Leukemia, B-Cell1

Trials

Showing 26 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.